Steady-state pharmacokinetics of isotretinoin and its 4-oxo metabolite: implications for fetal safety.

Steady-state pharmacokinetics of isotretinoin and its 4-oxo metabolite: implications for fetal safety.

Item
http://www.wikidata.org/entity/Q42686034
Blood Donors on Medication - an Approach to Minimize Drug Burden for Recipients of Blood Products and to Limit Deferral of DonorsPregnancy and isotretinoin therapy.Treatment of acne vulgaris in pregnant patients.A case of suspected isotretinoin-induced malformation in a baby of a mother who became pregnant one month after discontinuation of the drug.Nuclear retinoid receptors and pregnancy: placental transfer, functions, and pharmacological aspects.Congenital microtia in a neonate due to maternal isotretinoin exposure 1 month before pregnancy: Case Report.The metabolism and pharmacokinetics of isotretinoin in patients with acne and rosacea are not influenced by ethanol.Isotretinoin exposure and pregnancy outcome: an observational study of the Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy.Serum levels of albumin, triglycerides, total protein and glucose in rats are altered after oral treatment with low doses of 13-cis-retinoic acid or all-trans-retinoic acid.L-NAME cotreatment did prevent neither mitochondrial impairment nor behavioral abnormalities in adult Wistar rats treated with vitamin A supplementation.Steady state pharmacokinetics of oral treatment with 13-cis-retinoic acid or all-trans-retinoic acid in male and female adult rats.Disruption of mesoderm formation during cardiac differentiation due to developmental exposure to 13-cis-retinoic acid
P2860

Steady-state pharmacokinetics of isotretinoin and its 4-oxo metabolite: implications for fetal safety.

Item
http://www.wikidata.org/entity/Q42686034
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Steady-state pharmacokinetics ...... implications for fetal safety.
@en
Steady-state pharmacokinetics ...... implications for fetal safety.
@nl
type
label
Steady-state pharmacokinetics ...... implications for fetal safety.
@en
Steady-state pharmacokinetics ...... implications for fetal safety.
@nl
prefLabel
Steady-state pharmacokinetics ...... implications for fetal safety.
@en
Steady-state pharmacokinetics ...... implications for fetal safety.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Steady-state pharmacokinetics ...... implications for fetal safety.
@en
P2093
P2860
P304
P31
P356
10.1002/J.1552-4604.1998.TB04388.X
P433
P478
P577
P698
P921